dr. llombart-cussac on eribulin in her2-negative metastatic breast cancer
Published 7 years ago • 259 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
2:11
dr. llombart-cussac on the cascade study in metastatic breast cancer
-
5:25
eribulin in metastatic breast cancer
-
1:20
dr. o’shaughnessy on eribulin as first-line therapy for metastatic her2-negative breast cancer
-
1:00
dr. mcintyre on eribulin as first-line therapy in her2- breast cancer
-
3:40
treatment with eribulin in metastatic breast cancer
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
6:51
treatment with eribulin mesylate in metastatic breast cancer
-
1:36
dr. chris twelves compares eribulin and capecitabine
-
2:42
eribulin as treatment for metastatic breast cancer
-
0:59
dr. linda vahdat on frontline eribulin plus trastuzumab in her2-positive mbc
-
1:58
dr. alvarez on updated findings with eribulin in patients with her2 breast cancer
-
2:19
dr. twelves discusses eribulin for the treatment of breast cancer
-
2:08
dr. joyce o'shaughnessy on eribulin in metastatic breast cancer
-
1:17
dr. mcintyre on a phase ii study analyzing first-line eribulin mesylate
-
2:09
survival outcomes with balixafortide plus eribulin for patients with her2-metastatic breast cancer
-
9:49
patient selection for eribulin in breast cancer
-
3:33
eribulin in metastatic tnbc: real-world data
-
1:20
dr. edith perez on the etirinotecan pegol for her2-negative breast cancer
-
1:58
dr. twelves on a pooled analysis of eribulin in breast cancer